• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

载有阿魏酸的透明质酸修饰壳聚糖纳米颗粒:一种有前途的哮喘控制策略。

Aerosolized hyaluronic acid decorated, ferulic acid loaded chitosan nanoparticle: A promising asthma control strategy.

机构信息

Laboratory of Pulmonary Research, Department of Pharmaceutical Technology, Centre for Excellence in Nanobio Translational Research (CENTRE), University College of Engineering, Anna University, BIT Campus, Tiruchirappalli 620024, Tamil Nadu, India.

Department of In vivo Toxicology, Diligence Bio Pvt. Ltd., Pondicherry 605502, India.

出版信息

Int J Pharm. 2020 Dec 15;591:119958. doi: 10.1016/j.ijpharm.2020.119958. Epub 2020 Oct 22.

DOI:10.1016/j.ijpharm.2020.119958
PMID:33148522
Abstract

Vibrating mesh nebulizers are recognized as the most efficient actuation technique over conventional inhalers for drug deposition. This study explored hyaluronic acid (HA) decorated, ferulic acid (FA) loaded chitosan (CS) nanoparticle (FACHA) aerosolized using vibrating mesh nebulizer as strategic combination of drug, nanocarrier and delivery device for effective asthma control. FACHA exhibited spherical morphology with suitable size (164.2 ± 9.7 nm), zeta potential (24.0 ± 0.5 mV), entrapment efficiency (EE%) (65.0 ± 1.5), loading capacity (LC%) (18.5 ± 0.4) and mass median aerodynamic diameter (MMAD) of 1.81 ± 0.15 µm, ascertaining efficient drug deposition. In vivo inhalation toxicity assessment confirmed safety, while, FACHA prophylaxis mitigated inflammation, airway hypersensitivity and remodelling in ovalbumin (OVA) induced mice models. The results thus accentuated the role of pro-pulmonary surface chemistry conferred by HA functionalization that improved 1) thermal stability (thermogravimetric analysis - TGA) and 2) therapeutic efficacy of FA, by facilitating better interaction and transportation across mucus barrier, which otherwise suffers poor bioavailability and rapid metabolism.

摘要

振动网孔雾化器被认为是比传统吸入器更有效的药物沉积驱动技术。本研究探索了使用振动网孔雾化器雾化的透明质酸(HA)修饰、阿魏酸(FA)负载壳聚糖(CS)纳米颗粒(FACHA),作为药物、纳米载体和给药装置的战略组合,以有效控制哮喘。FACHA 呈现出合适大小(164.2±9.7nm)、Zeta 电位(24.0±0.5mV)、包封效率(EE%)(65.0±1.5)、载药量(LC%)(18.5±0.4)和质量中值空气动力学直径(MMAD)为 1.81±0.15μm 的球形形态,确保了药物的有效沉积。体内吸入毒性评估证实了其安全性,而 FACHA 预防可减轻卵清蛋白(OVA)诱导的小鼠模型中的炎症、气道高反应性和重塑。因此,结果强调了 HA 功能化赋予的亲肺表面化学性质的作用,这提高了 1)热稳定性(热重分析-TGA)和 2)FA 的治疗效果,通过促进更好的相互作用和穿过粘液屏障的运输,否则 FA 会遭受较差的生物利用度和快速代谢。

相似文献

1
Aerosolized hyaluronic acid decorated, ferulic acid loaded chitosan nanoparticle: A promising asthma control strategy.载有阿魏酸的透明质酸修饰壳聚糖纳米颗粒:一种有前途的哮喘控制策略。
Int J Pharm. 2020 Dec 15;591:119958. doi: 10.1016/j.ijpharm.2020.119958. Epub 2020 Oct 22.
2
Chitosan-hyaluronic acid nanoparticles loaded with heparin for the treatment of asthma.壳聚糖-透明质酸纳米载肝素治疗哮喘。
Int J Pharm. 2009 Nov 3;381(2):122-9. doi: 10.1016/j.ijpharm.2009.04.009. Epub 2009 Apr 15.
3
Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone.用于地塞米松眼部局部给药的透明质酸包被壳聚糖纳米粒的研制。
Int J Biol Macromol. 2016 Aug;89:127-36. doi: 10.1016/j.ijbiomac.2016.04.070. Epub 2016 Apr 25.
4
Systematically designed chitosan-coated solid lipid nanoparticles of ferulic acid for effective management of Alzheimer's disease: A preclinical evidence.系统设计的阿魏酸壳聚糖包覆固体脂质纳米粒用于阿尔茨海默病的有效管理:临床前证据。
Colloids Surf B Biointerfaces. 2021 Sep;205:111838. doi: 10.1016/j.colsurfb.2021.111838. Epub 2021 May 14.
5
PLGA Microparticles Entrapping Chitosan-Based Nanoparticles for the Ocular Delivery of Ranibizumab.包裹基于壳聚糖纳米颗粒的聚乳酸-羟基乙酸共聚物微粒用于雷珠单抗的眼部递送
Mol Pharm. 2016 Sep 6;13(9):2923-40. doi: 10.1021/acs.molpharmaceut.6b00335. Epub 2016 Jun 22.
6
Fabrication, characterization and optimization of nanostructured lipid carrier formulations using Beclomethasone dipropionate for pulmonary drug delivery via medical nebulizers.使用二丙酸倍氯米松制备、表征和优化载药纳米脂质体配方,通过医用雾化器进行肺部药物输送。
Int J Pharm. 2021 Apr 1;598:120376. doi: 10.1016/j.ijpharm.2021.120376. Epub 2021 Feb 20.
7
Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting.透明质酸修饰的倍他米松包封聚合物纳米粒的制备、表征、体外释放动力学及皮肤靶向性研究。
Drug Deliv Transl Res. 2019 Apr;9(2):520-533. doi: 10.1007/s13346-018-0480-1.
8
Use of combined nanocarrier system based on chitosan nanoparticles and phospholipids complex for improved delivery of ferulic acid.基于壳聚糖纳米粒子和磷脂复合物的联合纳米载体系统用于改善阿魏酸的递送。
Int J Biol Macromol. 2021 Feb 28;171:288-307. doi: 10.1016/j.ijbiomac.2020.12.211. Epub 2021 Jan 5.
9
Raloxifene-encapsulated hyaluronic acid-decorated chitosan nanoparticles selectively induce apoptosis in lung cancer cells.载雷洛昔芬的透明质酸修饰壳聚糖纳米粒选择性诱导肺癌细胞凋亡。
Bioorg Med Chem. 2019 Apr 15;27(8):1629-1638. doi: 10.1016/j.bmc.2019.03.004. Epub 2019 Mar 4.
10
Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid.壳聚糖包覆的聚乳酸-羟基乙酸共聚物纳米粒作为阿魏酸口服给药载体
Artif Cells Nanomed Biotechnol. 2018;46(sup2):993-1002. doi: 10.1080/21691401.2018.1477788. Epub 2018 May 29.

引用本文的文献

1
Syringic acid loaded chitosan nanoparticles mitigate glycation associated oxidative stress and inflammation in hyperglycaemic rat model.负载丁香酸的壳聚糖纳米颗粒减轻高血糖大鼠模型中与糖基化相关的氧化应激和炎症。
Sci Rep. 2025 Jul 2;15(1):22778. doi: 10.1038/s41598-025-05469-0.
2
Ferulic Acid as an Anti-Inflammatory Agent: Insights into Molecular Mechanisms, Pharmacokinetics and Applications.阿魏酸作为一种抗炎剂:对分子机制、药代动力学及应用的见解
Pharmaceuticals (Basel). 2025 Jun 18;18(6):912. doi: 10.3390/ph18060912.
3
Biomaterials for neuroengineering: applications and challenges.
用于神经工程的生物材料:应用与挑战。
Regen Biomater. 2025 Feb 21;12:rbae137. doi: 10.1093/rb/rbae137. eCollection 2025.
4
Production and Characterization of Nanoparticulate Polyelectrolyte Complexes of Chitosan-Catechol, Ulvan, and Hyaluronic Acid.壳聚糖-儿茶酚、岩藻依聚糖和透明质酸纳米级聚电解质复合物的制备与表征
ACS Omega. 2025 Jan 17;10(4):3474-3485. doi: 10.1021/acsomega.4c07429. eCollection 2025 Feb 4.
5
Breath and Beyond: Advances in Nanomedicine for Oral and Intranasal Aerosol Drug Delivery.呼吸与超越:用于口腔和鼻内气雾剂药物递送的纳米医学进展
Pharmaceuticals (Basel). 2024 Dec 23;17(12):1742. doi: 10.3390/ph17121742.
6
Chitosan-Based Nanoformulations: Preclinical Investigations, Theranostic Advancements, and Clinical Trial Prospects for Targeting Diverse Pathologies.壳聚糖基纳米制剂:针对多种病理的靶向治疗的临床前研究、治疗学进展和临床试验前景。
AAPS PharmSciTech. 2024 Nov 5;25(8):263. doi: 10.1208/s12249-024-02948-x.
7
Ferulic Acid: A Comprehensive Review.阿魏酸:综述
Cureus. 2024 Aug 28;16(8):e68063. doi: 10.7759/cureus.68063. eCollection 2024 Aug.
8
Preparation, Characterization, Antioxidant Activities, and Determination of Anti-Alzheimer Effects of PLGA-Based DDSs Containing Ferulic Acid.含阿魏酸的聚乳酸-羟基乙酸共聚物基药物递送系统的制备、表征、抗氧化活性及抗阿尔茨海默病作用的测定
ACS Omega. 2024 Feb 29;9(10):11321-11338. doi: 10.1021/acsomega.3c07289. eCollection 2024 Mar 12.
9
Advancements in Chitosan-Based Nanoparticles for Pulmonary Drug Delivery.用于肺部药物递送的壳聚糖基纳米颗粒的研究进展。
Polymers (Basel). 2023 Sep 21;15(18):3849. doi: 10.3390/polym15183849.
10
Advancing Treatment Strategies: A Comprehensive Review of Drug Delivery Innovations for Chronic Inflammatory Respiratory Diseases.推进治疗策略:慢性炎症性呼吸道疾病药物递送创新的全面综述
Pharmaceutics. 2023 Aug 17;15(8):2151. doi: 10.3390/pharmaceutics15082151.